Within NYC Opportunity, the Enterprise Data Solutions (EDS) team takes innovative approaches to link data in a meaningful way, as a means to help inform decision-making by City-wide stakeholder groups, including leadership, agencies, providers, and clients. EDS views data as a protected asset that can be responsibly leveraged across digital products to support analytical initiatives, facilitate knowledge sharing, and develop policy strategy.
The Application Developer (Java) is responsible for maintaining, supporting, and expanding our NYC Opportunity products. The Application Developer will be a key resource for the build of Java-based front-end, back-end, and ETL batch applications. This individual will coordinate with internal and external agencies to support batch and reporting needs.
We understand that candidates may not have all of the skills we are seeking below. We encourage those interested to apply even if they do not meet all of them. We are looking for talented individuals to join our team.
Master's degree in information systems, technology, or equivalent preferred with 7-10 years of experience in digital services and technology innovation.
This is a permanent, full-time position offering competitive salary and benefits. The salary range for this position is $100,000 - $130,000 commensurate with experience and qualifications.
To learn more about the New York City's Employee benefits, visit the NYC Office of Labor Relations.
Applicants must be authorized to work in the United States. We are unable to provide sponsorship to prospective employees.
Please fill out the application form. The form will prompt you to upload a resume and cover letter.
In addition to the application form, candidates will have to complete a separate application on the NYC job portal.
 
 
This position will require work from our office in Downtown Brooklyn. Please note that as of September 13, 2021, NYC government employees are no longer working remotely.
All new staff are required by the City of New York to be vaccinated against Covid-19.